These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
40 related articles for article (PubMed ID: 12534023)
1. How Dangerous Is Obesity? Issues in Measurement and Interpretation. Stokes A; Preston SH Popul Dev Rev; 2016 Dec; 42(4):595-614. PubMed ID: 28701804 [No Abstract] [Full Text] [Related]
2. [Drugs for arterial hypertension]. Gerard R; Balansard P Mars Med; 1971; 108(11):785-96. PubMed ID: 5158034 [No Abstract] [Full Text] [Related]
3. [Therapy of hypertension]. Heinrich F; Schultis K Med Welt; 1971 Jan; 3():108-13. PubMed ID: 5545598 [No Abstract] [Full Text] [Related]
4. [Moxonidine is advantageous for hypertensive type 2 diabetic patients. Therapy of hypertension also lowers HbA1c]. MMW Fortschr Med; 2003 Jan; 145(1-2):57. PubMed ID: 12638449 [No Abstract] [Full Text] [Related]
5. [Experiences with the new antihypertensive agent cyclazenine (Leron) in ambulant treatment of hypertension]. Linden HW Med Welt; 1966 Nov; 48():2638-41. PubMed ID: 5979466 [No Abstract] [Full Text] [Related]
6. Choosing the drug to treat hypertension. Drug Ther Bull; 1971 Sep; 9(20):77-9. PubMed ID: 5115091 [No Abstract] [Full Text] [Related]
8. [The treatment of obesity-related hypertension]. Skoczylas A Wiad Lek; 2006; 59(5-6):403-6. PubMed ID: 17017491 [TBL] [Abstract][Full Text] [Related]
9. Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension? Biaggioni I Hypertension; 2008 Feb; 51(2):168-71. PubMed ID: 18086947 [No Abstract] [Full Text] [Related]